HUMANIGEN
Humanigen is a biopharmaceutical company that uses its biologic capabilities and its proprietary platform technology to develop first-in-class human antibody therapeutics. It focuses on preventing the serious and potentially life-threatening side-effects associated with chimeric antigen receptor T-cell (CAR-T) therapy. Its pipeline includes programs such as Lenzilumab, Ifabotuzumab, and HGen005.
HUMANIGEN
Social Links:
Industry:
Biopharma Biotechnology Health Care Pharmaceutical
Founded:
2001-01-01
Address:
Burlingame, California, United States
Country:
United States
Website Url:
http://www.humanigen.com
Total Employee:
1+
Status:
Active
Contact:
650-243-3100
Email Addresses:
[email protected]
Total Funding:
369.45 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Content Delivery Network Google Universal Analytics Euro
Similar Organizations
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
AVEO Oncology
AVEO is a biopharmaceutical company that offers drug development strategies for targeted cancer therapeutics.
Day One Biopharmaceuticals
Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Immutep
Immutep is a biopharmaceutical company developing immunotherapeutics in oncology.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Recro Pharma
Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Verastem Oncology
Verastem is a biopharmaceutical company that focuses on discovering and developing novel drugs that selectively target cancer stem cells.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Hercules Capital
Hercules Capital investment in Post-IPO Debt - Humanigen
Cheval Holdings
Cheval Holdings investment in Post-IPO Equity - Humanigen
Nomis Bay
Nomis Bay investment in Post-IPO Equity - Humanigen
Black Horse Capital Advisors
Black Horse Capital Advisors investment in Post-IPO Equity - Humanigen
Fidelity
Fidelity investment in Private Equity Round - Humanigen
Alloy Ventures
Alloy Ventures investment in Series D - Humanigen
Mitsubishi UFJ Capital
Mitsubishi UFJ Capital investment in Series D - Humanigen
Sofinnova Investments
Sofinnova Investments investment in Series D - Humanigen
5AM Ventures
5AM Ventures investment in Series D - Humanigen
GBS Ventures
GBS Ventures investment in Series D - Humanigen
Key Employee Changes
Date | New article |
---|---|
2021-06-07 | Humanigen Announces Ken Trbovich Appointed as Senior Vice President, Investor Relations |
Official Site Inspections
http://www.humanigen.com Semrush global rank: 1.13 M Semrush visits lastest month: 28.57 K
- Host name: 147.62.236.23.bc.googleusercontent.com
- IP address: 23.236.62.147
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043